Ubicación: Global + English
Global Global Algérie Français Algeria English Angola Português Angola English Argentina Español Argentina English Australia English Austria Deutsch Austria English Azerbaijan English Azerbaijan Русский Bahrain English Bangladesh English Belgium English Belgium Français Belgium Nederlands Brazil Português Brazil English Bulgaria български Bulgaria English Cameroon English Cameroon Français Canada English Canada Français Chile Español Chile English China 中文 China 日本語 China English Colombia Español Colombia English Croatia English Czech Republic Čeština Czech Republic English Denmark English Djibouti English Ecuador Español Ecuador English Egypt English Estonia English Ethiopia English Finland Suomi Finland English France Français France English Georgia English Georgia Русский Germany Deutsch Germany English Ghana English Greece Ελληνικά Greece English Guatemala Español Guatemala English Hong Kong, China English Hong Kong, China 中文 Hungary Magyar Hungary English India English Indonesia English Iraq English Ireland English Italy Italiano Italy English Ivory Coast Français Ivory Coast English Japan 日本語 Japan English Jordan English Kazakhstan Русский Kazakhstan English Kenya English Kuwait English Kyrgyzstan Русский Kyrgyzstan English Latvia English Lithuania English Malaysia English Mauritius English Mauritius français (Maurice) Mexico Español Mexico English Moldova Română Moldova English Mongolia English Morocco English Morocco Français Mozambique Português Mozambique English Netherlands Nederlands Netherlands English New Zealand English Nigeria English Norway English Oman English Pakistan English Paraguay Español Paraguay English Peru Español Peru English Philippines English Poland Polski Poland English Portugal Português Portugal English Qatar English Republic of Korea 한국어 Republic of Korea English Romania Română Romania English Saudi Arabia English Serbia Српски Serbia English Singapore English Slovakia English Slovenia English South Africa English Spain English Spain Español Sri Lanka English Sweden English Switzerland Deutsch Switzerland Français Switzerland Italiano Switzerland English Tanzania English Thailand ไทย Thailand English Togo English Togo Français Tunisia English Tunisia Français Türkiye Türkçe Türkiye English Turkmenistan Русский Turkmenistan English Ukraine Українська Ukraine English United Arab Emirates English United Kingdom English Uruguay Español Uruguay English USA English Uzbekistan English Uzbekistan Русский Vietnam Tiếng Việt Vietnam English

The nuclear matrix isolation and extraction experiment is a fundamental cell biology technique used to separate the insoluble protein scaffold of the cell nucleus from soluble proteins, membranes, and bulk chromatin DNA. Through sequential detergent lysis, nuclease digestion, and high-salt extraction, researchers obtain structurally intact nuclear matrix preparations suitable for morphological, biochemical, and diagnostic analysis. This article presents a comprehensive overview of the experimental principles, applicable sample types, testing items, standard operating procedures, quality control criteria, and typical applications of nuclear matrix isolation.

Technical Overview

The nuclear matrix is a dynamic, insoluble fibrillar network of proteins and associated RNA that permeates the interior of the eukaryotic cell nucleus. Structurally, it comprises the peripheral nuclear lamina (composed primarily of lamins A, B, and C), an internal fibrogranular protein network, residual nucleolar components, and the remaining pore complex-associated structures. Functionally, the nuclear matrix serves as an organizational platform for chromatin looping, DNA replication foci, transcription sites, RNA processing centers, and the anchoring of matrix attachment regions (MARs, also termed scaffold attachment regions, SARs).

The core principle of the nuclear matrix isolation and extraction experiment is sequential biochemical fractionation. First, a nonionic detergent such as Triton X-100, NP-40, or digitonin permeabilizes cellular and nuclear membranes, releasing soluble cytoplasmic and nucleoplasmic proteins. Second, mild digestion with deoxyribonuclease I (DNase I), often combined with ribonuclease A, cleaves chromosomal DNA into soluble fragments. Third, high-salt extraction with 0.2 M ammonium sulfate or 1 to 2 M sodium chloride removes histones, digested DNA fragments, and remaining soluble proteins. The residual structure, which retains nuclear size, shape, and spatial organization, represents the nuclear matrix fraction.

The resulting preparation typically contains approximately 10 to 15 percent of total nuclear protein and retains only about 2 to 5 percent of total nuclear DNA, which is enriched in MAR/SAR sequences, replication origins, and AT-rich regions. Major protein constituents identified in nuclear matrix fractions include lamins A/C and B, DNA topoisomerase II, matrin 3, nuclear mitotic apparatus protein (NuMA), heterogeneous nuclear ribonucleoproteins (hnRNPs), and special AT-rich sequence-binding protein 1 (SATB1).

Testing Samples

Cultured Mammalian Cells

Adherent and suspension cell lines such as HeLa, HEK293, HepG2, MCF-7, and primary fibroblasts are the most common starting materials. A typical preparation requires 10 to the power of 6 to 10 to the power of 8 cells harvested during logarithmic growth phase, ideally at 70 to 80 percent confluence. Human-derived cell lines should be handled under appropriate biosafety level 2 containment in accredited laboratories.

Animal Tissue Specimens

Fresh tissues such as rat liver, thymus, kidney, and tumor biopsies can be used after mechanical homogenization and isolation of intact nuclei through sucrose density gradient centrifugation. Tissue samples should be processed promptly or cryopreserved under validated conditions to prevent proteolytic degradation of matrix proteins.

Plant Materials

Plant cells require additional pretreatment because the cell wall resists detergent lysis. Enzymatic digestion with cellulase and pectinase to generate protoplasts, or controlled mechanical disruption followed by nuclei isolation, is performed before the standard extraction sequence.

Pre-Isolated Nuclei Preparations

Nuclei previously purified through sucrose or iodixanol gradient centrifugation can serve directly as the starting material, which shortens the workflow and reduces cytoplasmic contamination. Purity of the nuclei fraction should be verified microscopically before matrix extraction.

Testing Items

A complete nuclear matrix isolation and extraction experiment generally includes the following analytical and quality control items:

  • Morphological integrity assessment using phase-contrast microscopy, DAPI or propidium iodide staining, and fluorescence or confocal microscopy
  • Ultrastructural verification using transmission electron microscopy to confirm the filamentous network and residual nucleoli
  • Protein composition profiling by SDS-PAGE and quantitative protein assays
  • Western blot identification of marker proteins, including lamins A/C and B, topoisomerase II, NuMA, and matrin 3
  • Residual DNA quantification and analysis of retained matrix attachment region sequences by gel electrophoresis or quantitative PCR
  • Matrix-associated RNA content determination
  • Topoisomerase II enzymatic activity assay in the matrix fraction
  • Contamination assessment using markers for cytoskeleton, endoplasmic reticulum, and soluble nucleoplasm
  • Mass ratio determination of residual protein to residual DNA as a consistency indicator

Testing Methods

Classic High-Salt Extraction Protocol

The most widely adopted procedure follows the principles established in classical nuclear matrix research. Cells are first washed with ice-cold phosphate-buffered saline and lysed in a PIPES-based cytoskeleton buffer containing 10 mM PIPES at pH 6.8, 100 mM sodium chloride, 300 mM sucrose, 3 mM magnesium chloride, 1 mM EGTA, and 0.5 percent Triton X-100, supplemented with protease inhibitors, for 3 to 5 minutes on ice. The preparation is then extracted with an identical buffer in which the salt is replaced by 250 mM ammonium sulfate to strip intermediate filaments and soluble nuclear proteins. Chromatin is digested with DNase I and RNase A at approximately 100 micrograms per milliliter each for 15 to 30 minutes, followed by a second ammonium sulfate extraction to elute the digested DNA fragments. The final insoluble fraction is washed, fixed for microscopy, or solubilized in electrophoresis sample buffer for protein analysis.

Two-Molar Sodium Chloride Method

When working from purified nuclei, chromatin can be removed by DNase I digestion followed by extraction with 2 M sodium chloride and Triton X-100. This approach efficiently removes histones H1, H2A, H2B, H3, and H4 while preserving the lamina and internal matrix network, and it is well suited for comparative protein composition studies.

Mild Detergent LIS Method

Extraction with 20 mM lithium 3,5-diiodosalicylate provides gentle histone removal under near-physiological ionic strength, which better preserves protein-protein interactions and is preferred when downstream enzyme activity assays or immunoprecipitation are planned.

Cross-Linking Stabilized Approaches

For cytological examination of in situ nuclear organization, samples may be lightly stabilized with agents such as cis-diamminedichloroplatinum II or low-concentration paraformaldehyde before extraction. This preserves labile internal matrix structures that could otherwise be lost during high-salt treatment.

Quality Control and Validation Criteria

A successful preparation is confirmed by several criteria: nuclear morphology remains intact under phase-contrast microscopy; DAPI staining shows removal of more than 95 percent of bulk DNA; SDS-PAGE reveals the characteristic matrix protein pattern; and Western blotting confirms enrichment of lamins and topoisomerase II. Laboratories performing this work routinely operate under documented quality management systems consistent with ISO/IEC 17025 requirements for competent testing laboratories, including calibrated equipment, validated reagents, controlled environmental conditions, and traceable documentation.

Applications

Nuclear matrix isolation and extraction experiments support a broad range of research, clinical, and biotechnological applications:

  • Investigation of nuclear architecture and higher-order chromatin domain organization
  • Mapping of DNA replication forks and transcriptionally active gene sites through in situ matrix assays
  • Identification and cloning of matrix attachment regions and scaffold attachment regions involved in gene regulation
  • Discovery of cancer-associated nuclear matrix protein biomarkers for bladder, breast, colon, and prostate tumors
  • Study of viral replication complexes that associate with the nuclear scaffold
  • Analysis of apoptosis-related nuclear breakdown and lamin cleavage by caspases
  • Cell cycle research on matrix reorganization during mitosis and S phase
  • Screening of pharmaceutical compounds and toxic agents that affect nuclear structure or topoisomerase II activity
  • Comparative proteomics of normal versus transformed cells using mass spectrometry of matrix fractions

FAQ

What is the difference between the nuclear matrix and the nuclear lamina?

The nuclear lamina is the protein meshwork lining the inner nuclear membrane, composed mainly of lamins. The nuclear matrix is a broader concept that includes the lamina plus the internal fibrogranular network and residual nucleolar skeleton extending throughout the nucleoplasm.

Why is high-salt extraction necessary in the protocol?

High salt disrupts ionic interactions between histones and DNA, allowing the digestion products of chromatin to be eluted while the covalently and strongly non-covalently associated matrix proteins remain insoluble. This step is essential for isolating a clean protein scaffold fraction.

How can I confirm that the isolation was successful?

Validation combines microscopy, which should show intact nuclear morphology with minimal DNA staining, and biochemistry, which should show the expected matrix protein profile with lamin and topoisomerase II enrichment and removal of more than 95 percent of nuclear DNA.

How much DNA remains attached to the matrix after extraction?

Typically 2 to 5 percent of total nuclear DNA is retained. This residual DNA is not random; it is highly enriched in matrix attachment regions, replication origins, and regulatory sequences.

Can frozen samples be used as starting material?

Cryopreserved cell pellets and tissues can be used, but freeze-thaw cycles may partially disrupt labile internal matrix structures. Fresh samples are strongly recommended when downstream structural or enzymatic analyses are planned.

What are the most common causes of matrix disruption?

Frequent causes include excessive mechanical shearing, omission or failure of protease inhibitors, overly vigorous nuclease digestion, incorrect buffer pH or magnesium concentration, and prolonged extraction times beyond validated limits.

Is the isolated matrix fraction compatible with mass spectrometry?

Yes. The matrix fraction is well suited for LC-MS/MS-based proteomic profiling because it is highly enriched for structural and regulatory proteins, and many published biomarker discovery studies are built on this preparation.